Envestnet Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,690
Closed -$25K 2000
2018
Q2
$25K Sell
1,690
-3
-0.2% -$42 ﹤0.01% 2374
2018
Q1
$22K Buy
1,693
+124
+8% +$1.63K ﹤0.01% 2343
2017
Q4
$20K Sell
1,569
-244
-13% -$3.08K ﹤0.01% 2522
2017
Q3
$23K Sell
1,813
-47
-3% -$620 ﹤0.01% 2467
2017
Q2
$28K Sell
1,860
-241
-11% -$3.35K ﹤0.01% 2524
2017
Q1
$25K Buy
2,101
+1
+0% +$13 ﹤0.01% 2627
2016
Q4
$29K Buy
2,100
+296
+16% +$4.1K ﹤0.01% 2580
2016
Q3
$24K Buy
1,804
+658
+57% +$7.97K ﹤0.01% 2785
2016
Q2
$12K Sell
1,146
-133
-10% -$1.47K ﹤0.01% 3021
2016
Q1
$13K Sell
1,279
-1,203
-48% -$13.2K ﹤0.01% 3020
2015
Q4
$29K Sell
2,482
-2,170
-47% -$26.6K ﹤0.01% 2821
2015
Q3
$54K Buy
+4,652
New +$61.6K ﹤0.01% 2619
2015
Q1
Sell
-1,992
Closed -$28K 2246
2014
Q4
$28K Buy
1,992
+104
+6% +$1.34K ﹤0.01% 1639
2014
Q3
$23K Buy
1,888
+1,055
+127% +$13.2K ﹤0.01% 1820
2014
Q2
$10K Buy
833
+609
+272% +$7.17K ﹤0.01% 2036
2014
Q1
$2K Buy
+224
New +$2.46K ﹤0.01% 2299
2013
Q4
Sell
-124
Closed -$2K 2505
2013
Q3
$2K Sell
124
-217
-64% -$3.03K ﹤0.01% 2165
2013
Q2
$5K Buy
+341
New +$4.71K ﹤0.01% 1882

Other funds holding LFCR

Envestnet Asset Management's LFCR Position: Q3 2018 in Review

Envestnet Asset Management sold out of Lifecore Biomedical (LFCR) in Q3 2018, closing a stake of 1,690 shares — an estimated $25K sold.

Envestnet Asset Management first reported a position in LFCR in Q2 2013 and held it in 18 quarters. The position peaked at $54K in Q3 2015. 90 funds tracked by Wall St. Rank hold LFCR as of Q3 2018.

  • Envestnet Asset Management reported no remaining Lifecore Biomedical position as of Q3 2018 after selling out during the quarter.
  • Envestnet Asset Management sold 1,690 Lifecore Biomedical shares in Q3 2018, an estimated $25K.
  • Envestnet Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 18 quarters.
  • Envestnet Asset Management's Lifecore Biomedical position peaked at $54K in Q3 2015.
  • 90 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2018.

Based on Envestnet Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.